These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 10900011
1. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Schoenfeld AR, Davidowitz EJ, Burk RD. Proc Natl Acad Sci U S A; 2000 Jul 18; 97(15):8507-12. PubMed ID: 10900011 [Abstract] [Full Text] [Related]
2. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ, Maher ER. Oncogene; 2001 Aug 16; 20(36):5067-74. PubMed ID: 11526493 [Abstract] [Full Text] [Related]
6. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG. Science; 1995 Sep 08; 269(5229):1444-6. PubMed ID: 7660130 [Abstract] [Full Text] [Related]
8. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Feldman DE, Thulasiraman V, Ferreyra RG, Frydman J. Mol Cell; 1999 Dec 16; 4(6):1051-61. PubMed ID: 10635329 [Abstract] [Full Text] [Related]
9. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD. Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2156-61. PubMed ID: 9122164 [Abstract] [Full Text] [Related]
10. The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression. Pioli PA, Rigby WF. J Biol Chem; 2001 Oct 26; 276(43):40346-52. PubMed ID: 11517223 [Abstract] [Full Text] [Related]
12. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein. Bonicalzi ME, Groulx I, de Paulsen N, Lee S. J Biol Chem; 2001 Jan 12; 276(2):1407-16. PubMed ID: 11024059 [Abstract] [Full Text] [Related]
13. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Tsuchiya H, Iseda T, Hino O. Cancer Res; 1996 Jul 01; 56(13):2881-5. PubMed ID: 8674032 [Abstract] [Full Text] [Related]
16. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Pause A, Peterson B, Schaffar G, Stearman R, Klausner RD. Proc Natl Acad Sci U S A; 1999 Aug 17; 96(17):9533-8. PubMed ID: 10449727 [Abstract] [Full Text] [Related]
18. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD. Mol Cell Biol; 1999 Feb 17; 19(2):1486-97. PubMed ID: 9891082 [Abstract] [Full Text] [Related]
19. The von Hippel-Lindau tumour suppressor protein: new perspectives. Ohh M, Kaelin WG. Mol Med Today; 1999 Jun 17; 5(6):257-63. PubMed ID: 10366821 [Abstract] [Full Text] [Related]